Clinical Trial Update: Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing insulin dosing algorithms using hepatic-directed vesicle-insulin lispro and insulin degludec in adults with type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)
• insulin lispro (hepatic-directed vesicle encapsulated) (insulin lispro)

Snippet

Sponsor: Diasome Pharmaceuticals | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED